SolvixLMS is currently in alpha at one of the largest solventless extraction facilities in the U.S., serving as the first proof of the platform thesis. The company is transitioning from a cannabis-focused holding company to a pure technology play targeting operator-first software for mission-critical industries, with plans to expand beyond cannabis extraction applications.
Cyborg Score Rationale
Early-stage technology company with ambitious AI-native vertical software thesis but facing significant execution risk. Currently pre-revenue with launch scheduled for June 2026 and name change in progress. OTC listing and limited market visibility present additional challenges.
Top Insights
Strategic pivot from cannabis operations to AI-native software infrastructure represents significant business model transformation (2026)
SolvixLMS scheduled for public launch June 15, 2026, with initial deployment in solventless cannabis extraction but designed for multi-vertical expansion
Company is pre-revenue, making success heavily dependent on post-launch execution and market adoption
Corporate name change to Cyphaira Corp in process; ticker (GSTK), reporting status, and operating subsidiary remain unchanged